Review Article Online Published: 25 Oct 2023 | ||||||||||||
IJMDC. 2023; 7(12): 1979-1986 Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023 Abdullah K. Dakhel, Mohammad B. Aldeaiji, Sultan H. Alharbi, Abdullah M. Alhazmi, Omar B. Bawazir, Abdullah H. Alharbi, Mohammed K. Dakhel.
|
How to Cite this Article |
Pubmed Style Dakhel AK, Aldeaiji MB, Alharbi SH, Alhazmi AM, Bawazir OB, Alharbi AH, Dakhel MK. Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. IJMDC. 2023; 7(12): 1979-1986. doi:10.24911/IJMDC.51-1696257618 Web Style Dakhel AK, Aldeaiji MB, Alharbi SH, Alhazmi AM, Bawazir OB, Alharbi AH, Dakhel MK. Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. https://www.ijmdc.com/?mno=171751 [Access: December 28, 2024]. doi:10.24911/IJMDC.51-1696257618 AMA (American Medical Association) Style Dakhel AK, Aldeaiji MB, Alharbi SH, Alhazmi AM, Bawazir OB, Alharbi AH, Dakhel MK. Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. IJMDC. 2023; 7(12): 1979-1986. doi:10.24911/IJMDC.51-1696257618 Vancouver/ICMJE Style Dakhel AK, Aldeaiji MB, Alharbi SH, Alhazmi AM, Bawazir OB, Alharbi AH, Dakhel MK. Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. IJMDC. (2023), [cited December 28, 2024]; 7(12): 1979-1986. doi:10.24911/IJMDC.51-1696257618 Harvard Style Dakhel, A. K., Aldeaiji, . M. B., Alharbi, . S. H., Alhazmi, . A. M., Bawazir, . O. B., Alharbi, . A. H. & Dakhel, . M. K. (2023) Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. IJMDC, 7 (12), 1979-1986. doi:10.24911/IJMDC.51-1696257618 Turabian Style Dakhel, Abdullah K., Mohammad B. Aldeaiji, Sultan H. Alharbi, Abdullah M. Alhazmi, Omar B. Bawazir, Abdullah H. Alharbi, and Mohammed K. Dakhel. 2023. Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. International Journal of Medicine in Developing Countries, 7 (12), 1979-1986. doi:10.24911/IJMDC.51-1696257618 Chicago Style Dakhel, Abdullah K., Mohammad B. Aldeaiji, Sultan H. Alharbi, Abdullah M. Alhazmi, Omar B. Bawazir, Abdullah H. Alharbi, and Mohammed K. Dakhel. "Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023." International Journal of Medicine in Developing Countries 7 (2023), 1979-1986. doi:10.24911/IJMDC.51-1696257618 MLA (The Modern Language Association) Style Dakhel, Abdullah K., Mohammad B. Aldeaiji, Sultan H. Alharbi, Abdullah M. Alhazmi, Omar B. Bawazir, Abdullah H. Alharbi, and Mohammed K. Dakhel. "Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023." International Journal of Medicine in Developing Countries 7.12 (2023), 1979-1986. Print. doi:10.24911/IJMDC.51-1696257618 APA (American Psychological Association) Style Dakhel, A. K., Aldeaiji, . M. B., Alharbi, . S. H., Alhazmi, . A. M., Bawazir, . O. B., Alharbi, . A. H. & Dakhel, . M. K. (2023) Comparative study of pharmacokinetics, pharmacodynamics and cost-effectiveness between first-line Angiotensin Converting Enzyme inhibitors in Saudi Arabia during 2023. International Journal of Medicine in Developing Countries, 7 (12), 1979-1986. doi:10.24911/IJMDC.51-1696257618 |